Document Detail


Propofol hemisuccinate protects neuronal cells from oxidative injury.
MedLine Citation:
PMID:  10582614     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oxidative stress contributes to the neuronal death observed in neurodegenerative disorders and neurotrauma. Some antioxidants for CNS injuries, however, have yet to show mitigating effects in clinical trials, possibly due to the impermeability of antioxidants across the blood-brain barrier (BBB). Propofol (2,6-diisopropylphenol), the active ingredient of a commonly used anesthetic, acts as an antioxidant, but it is insoluble in water. Therefore, we synthesized its water-soluble prodrug, propofol hemisuccinate sodium salt (PHS), and tested for its protective efficacy in neuronal death caused by non-receptor-mediated, oxidative glutamate toxicity. Glutamate induces apoptotic death in rat cortical neurons and the mouse hippocampal cell line HT-22 by blocking cystine uptake and causing the depletion of intracellular glutathione, resulting in the accumulation of reactive oxygen species (ROS). PHS has minimal toxicity and protects both cortical neurons and HT-22 cells from glutamate. The mechanism of protection is attributable to the antioxidative property of PHS because PHS decreases the ROS accumulation caused by glutamate. Furthermore, PHS protects HT-22 cells from oxidative injury induced by homocysteic acid, buthionine sulfoximine, and hydrogen peroxide. For comparison, we also tested alpha-tocopherol succinate (TS) and methylprednisolone succinate (MPS) in the glutamate assay. Although TS is protective against glutamate at lower concentrations than PHS, TS is toxic to HT-22 cells. In contrast, MPS is nontoxic but also nonprotective against glutamate. Taken together, PHS, a water-soluble prodrug of propofol, is a candidate drug to treat CNS injuries owing to its antioxidative properties, low toxicity, and permeability across the BBB.
Authors:
Y Sagara; S Hendler; S Khoh-Reiter; G Gillenwater; D Carlo; D Schubert; J Chang
Related Documents :
17673354 - Neurotensin receptor mechanisms and its modulation of glutamate transmission in the bra...
9600674 - Spinal cord glt-1 glutamate transporter and blood glutamic acid alterations in motor ne...
11885654 - Neurotransmission of the cochlear inner hair cell synapse--implications for inner ear t...
11340204 - Control of glutamate clearance and synaptic efficacy by glial coverage of neurons.
9712154 - Tgf-beta receptor expression on human keratinocytes: a 150 kda gpi-anchored tgf-beta1 b...
9392444 - The role of the intracellular and extracellular serotonin in the regulation of melatoni...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of neurochemistry     Volume:  73     ISSN:  0022-3042     ISO Abbreviation:  J. Neurochem.     Publication Date:  1999 Dec 
Date Detail:
Created Date:  1999-12-27     Completed Date:  1999-12-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2985190R     Medline TA:  J Neurochem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2524-30     Citation Subset:  IM    
Affiliation:
Salk Institute for Biological Studies, La Jolla 92037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects
Buthionine Sulfoximine / pharmacology
Glutamic Acid / toxicity
Hippocampus / cytology
Homocysteine / analogs & derivatives,  pharmacology
Hydrogen Peroxide / pharmacology
Methylprednisolone / pharmacology
Mice
Neurons / drug effects*
Neuroprotective Agents / pharmacology*
Neurotoxins / pharmacology
Oxidative Stress
Propofol / pharmacology*
Rats
Reactive Oxygen Species
Tocopherols
Vitamin E / analogs & derivatives,  pharmacology
Grant Support
ID/Acronym/Agency:
5PO1NS28121/NS/NINDS NIH HHS; F32NS10032/NS/NINDS NIH HHS; R01NS09658/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 0/Neurotoxins; 0/Reactive Oxygen Species; 1001-13-4/homocysteic acid; 1406-18-4/Vitamin E; 1406-66-2/Tocopherols; 2078-54-8/Propofol; 454-28-4/Homocysteine; 5072-26-4/Buthionine Sulfoximine; 56-86-0/Glutamic Acid; 7722-84-1/Hydrogen Peroxide; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling.
Next Document:  A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions...